Renal Angiomyolipoma (AML)

Definition and Classification

• Sporadic - most common form, predominantly in women, peak incidence 4th-5th decade
• Syndrome-associated - tuberous sclerosis complex (TSC), lymphangioleiomyomatosis (LAM)
• Campbell-Walsh-Wein Urology, p. 2294

Epidemiology

Pathophysiology and Genetics

• Mutations in TSC1 (hamartin, chromosome 9q34) or TSC2 (tuberin, chromosome 16p13)
• Inheritance: autosomal dominant, variable penetrance; sporadic mutations are common
• Hamartin-tuberin dimer normally inhibits mTOR - loss of function leads to unregulated mTOR activation
• Downstream: uncontrolled protein synthesis, cellular proliferation, and angiogenesis

Histopathology

• Tumors are well-circumscribed with a tan, pink, or yellow cut surface (depending on fat content)
• Composed of thick-walled eccentric blood vessels, smooth muscle spindle cells, and mature adipocytes (no atypia in classic form)
• Immunohistochemistry: Spindle cells have melanocytic features - positive for HMB-45 and Melan-A (key markers)
• AMLs also strongly express estrogen receptor-beta, progesterone receptor, and androgen receptor - explains the female preponderance postpuberty

• Minimal fat, abundance of epithelioid cells
• Frequent atypia, mitotic figures, and necrosis
• Metastatic potential - reported in ~1/3 of cases (sporadic and TSC-associated)
• Should be considered potentially malignant
• Campbell-Walsh-Wein Urology, p. 2305-2307

Clinical Presentation

• Most are asymptomatic - incidentally detected on imaging
• Wunderlich syndrome (spontaneous retroperitoneal hemorrhage) - historically up to 15% of patients; AML is the most common cause of spontaneous retroperitoneal hemorrhage
• Flank/loin pain, flank mass, hematuria
• Pregnancy is a risk factor for hemorrhage (due to hormonal receptor positivity)

Diagnosis and Imaging

CT (Gold Standard)

• Intralesional fat density of -15 to -20 Hounsfield units (HU) on non-contrast series is diagnostic
• Cutoff of -10 HU gives a c-index of 0.83
• Fat on CT = definitive diagnosis - no biopsy needed

Ultrasound

• Hyperechoic (bright echogenic) mass - due to high fat content
• Less reliable; RCC can also appear hyperechoic
• Subcentimeter echogenic lesions are usually clinically insignificant

MRI

• AML follows signal intensity of intraabdominal fat on all sequences
• Loses signal on fat-saturated sequences
• India ink artifact on out-of-phase sequences at fat-water interface is diagnostic
• Non-fat components enhance avidly

MRI T1 in-phase sequence: AML in right kidney following fat signal intensity (arrow)

• National Kidney Foundation Primer on Kidney Diseases, p. 77; Bailey and Love's Surgery, p. 1503

Management

Observation (Watchful Waiting)

• Tumors < 4 cm in asymptomatic patients can be followed with surveillance CT or MRI
• The traditional 4 cm cutoff for intervention has recently been questioned - some advocate individualized assessment

Selective Renal Angioembolization (SAE)

• Treatment of choice for acute hemorrhage
• Also used prophylactically for high-risk lesions (classically >4 cm)
• Technique: transfemoral/transradial approach, superselective catheterization of feeding vessels
• Embolics: ethanol + ethiodized oil (7:3 ratio) - ethanol provides permanent occlusion; ethiodized oil is radiopaque for monitoring
• Freedom from surgical intervention at 5 years: 94% after SAE
• Recurrence of hemorrhage: ~10-15%, managed by repeat embolization
• A short-term tapered prednisone course may reduce post-embolization syndrome (PES)
• A 2025 systematic review (PMID: 40165158) confirms safety and efficacy of SAE

Nephron-Sparing Surgery (Partial Nephrectomy)

• Preferred surgical option when intervention is needed
• Preferred over radical nephrectomy to preserve renal function
• Robot-assisted approaches are increasingly used; a 2025 meta-analysis (PMID: 41372556) compared robot-assisted vs. laparoscopic partial nephrectomy

mTOR Inhibitors

• Everolimus and sirolimus - indicated for larger, multifocal AMLs in TSC and LAM patients
• Target the dysregulated mTOR pathway
• Shown to reduce tumor size; excellent response rates in TSC-associated AML
• Everolimus is FDA-approved specifically for this indication

Summary Decision Framework

• Campbell-Walsh-Wein Urology, p. 2378-2382; Bailey and Love's Surgery, p. 1503

Key Points Summary

1. Benign PEComa - composed of blood vessels, smooth muscle, and fat; sporadic or TSC/LAM-associated
2. TSC link - TSC1/TSC2 mutations -> loss of mTOR inhibition -> uncontrolled cell growth
3. Diagnosis by imaging - macroscopic fat on CT (-15 to -20 HU) is pathognomonic
4. Fat-poor AML (~4%) mimics RCC - requires biopsy
5. Epithelioid AML - aggressive variant with malignant potential; HMB-45 positive
6. Hemorrhage risk increases with size; AML is the leading cause of spontaneous retroperitoneal hemorrhage (Wunderlich syndrome)
7. Angioembolization for acute bleeding; everolimus for TSC-associated multifocal disease
8. 4 cm threshold has traditionally guided intervention, though now subject to individualized assessment

Recent evidence note: Two 2025 systematic reviews confirm the role of SAE in AML management [PMID: 40165158] and support robot-assisted partial nephrectomy as a viable surgical option [PMID: 41372556]. Neither appears to fundamentally alter established guidelines from textbook evidence.